ACE inhibitors (eg, captopril) Increased risk of hypotension, especially in patients with acute MI; bronchial hyper-reactivity may be increased.
Aluminum hydroxide gel Greatly reduces GI absorption of propranolol.
Amiodarone Has additive antiarrhythmic and negative chronotropic properties with propranolol.
Anesthetic agents (eg, methoxyflurane, trichloroethylene) Depression in myocardial contractility may occur.
Barbiturates Decreased bioavailability of propranolol.
Cimetidine Increased propranolol levels.
Clonidine Attenuation or reversal of antihypertensive effect; potentially life-threatening increases in BP, especially on withdrawal.
Disopyramide Has been associated with severe bradycardia, asystole, and heart failure, when given with propranolol.
Dobutamine, isoproterenol May reverse effects of propranolol.
Epinephrine Initial hypertensive episode followed by bradycardia.
Ergot derivatives Peripheral ischemia, manifested by cold extremities and possible gangrene.
Ethanol Slows rate of propranolol absorption.
Hydantoins, rifabutin, rifampin Decreased effects of propranolol.
Hydralazine Increased serum levels of both drugs.
Insulin Prolonged hypoglycemia with masking of symptoms.
Lidocaine Increased lidocaine levels, leading to toxicity.
Methimazole, propafenone, propylthiouracil, quinidine Increased effects of propranolol.
NSAIDs Some agents may impair antihypertensive effect.
Phenothiazines Increased effects of either drug.
Prazosin Increased orthostatic hypotension.
Reserpine Hypotension, marked bradycardia, vertigo, syncopal attacks, and orthostatic hypotension may result from excessive reduction of resting sympathetic nervous activity caused by reserpine-induced catecholamine-depletion.
Theophylline Reduces elimination of theophylline; pharmacologic antagonism.
Thyroxine May result in decreased T 3 concentration when coadministered with propranolol.
Verapamil Increased effects of both drugs.
|